Royal Bank Of Canada Sesen Bio, Inc. Transaction History

Royal Bank Of Canada

7 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q4 2022 Feb 14, 2023	SELL	$0.49 - $0.61 $322 - $401	-658 Reduced 61.15%	418 $0
Q3 2022 Nov 14, 2022	BUY	$0.0 - $0.93 $0 - $727	782 Added 265.99%	1,076 $0
Q2 2022 Aug 15, 2022	SELL	$0.38 - $0.89 $5,234 - $12,258	-13,774 Reduced 97.91%	294 $0
Q1 2022 May 16, 2022	SELL	$0.58 - $0.86 $18,938 - $28,080	-32,652 Reduced 69.89%	14,068 $8,000
Q4 2021 Feb 14, 2022	BUY	$0.73 - $1.28 $17,733 - $31,093	24,292 Added 108.31%	46,720 $38,000
Q3 2021 Nov 15, 2021	BUY	$0.77 - $4.91 $8,155 - $52,006	10,592 Added 89.49%	22,428 $17,000
Q2 2021 Aug 16, 2021	BUY	$2.18 - $4.66 $25,802 - $55,155	11,836 New	11,836 $55,000

Ticker SESN
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 201,702,000
Market Cap $127M
Description
Sesen Bio, Inc., a late-stage clinical company, focuses on designing, engineering, developing, and commercializing targeted fusion protein therapeutics (TFPTs) for the treatment patients with cancer. Its lead product candidates include Vicineum, a locally-administered targeted fusion protein that is in Phase III clinical trials for the treatment...

Get notified when there are updates to the investment portfolio of Royal Bank Of Canada, based on Form 13F filings with the SEC.

Stay updated on Royal Bank Of Canada with notifications on news.